Pembrolizumab and chemoradiotherapy for muscle invasive bladder cancer: The ANZUP 1502 PCR-MIB trial. Background: Immune checkpoint inhibitors (CPIs) are approved for patients (pts) with locally ...
Safety and activity of M7824, a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with HPV associated cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results